Ascariasis, filariasis

Active Ingredient: Albendazole

Indication for Albendazole

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

ฮ‘lbendazole is effective against ascariasis, filariasis.

For this indication, competent medicine agencies globally authorize below treatments:

400 mg daily

Route of admnistration

Oral

Defined daily dose

400 mg

Dosage regimen

400 mg once every day for 3 day(s)

Detailed description

400mg daily for 3 days.

Dosage considerations

Should be taken with meal.

Active ingredient

Albendazole

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Read more about Albendazole

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.